On October 18, 2024, the Federal Circuit issued its opinion in UTTO Inc. v. Metrotech Corp., No. 2023-1435, 2024 U.S. App.
To close out the year, 4 senators came together to introduce a new bipartisan bill to protect biosimilar and generic drug ...